Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freedman, M. S.
Right arrow Articles by Pachner, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, M. S.
Right arrow Articles by Pachner, A. R.
Related Collections
Right arrow MRI
Right arrow All Immunology
Right arrow All Clinical Neurology
Right arrow Multiple sclerosis
Right arrowRelated Article
Neurology, Vol. 69, Issue 14, 1386-1387, October 2, 2007

EDITORIALS

Neutralizing antibodies to biological therapies: A "touch of gray" vs a "black and white" story

Mark S. Freedman and Andrew R. Pachner

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:


Related Article

The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL
P. A. Calabresi, G. Giovannoni, C. Confavreux, S. L. Galetta, E. Havrdova, M. Hutchinson, L. Kappos, D. H. Miller, P. W. O'Connor, J. T. Phillips, C. H. Polman, E. -W. Radue, R. A. Rudick, W. H. Stuart, F. D. Lublin, A. Wajgt, B. Weinstock-Guttman, D. R. Wynn, F. Lynn, M. A. Panzara For the AFFIRM and SENTINEL Investigators
Neurology 2007 69: 1391-1403. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 NeurologyHome page
A. R. Pachner, D. Cadavid, L. Wolansky, and J. Skurnick
Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study
Neurology, November 3, 2009; 73(18): 1485 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. S. Brinch, N. Frimodt-Moller, N. Hoiby, and H.-H. Kristensen
Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics
Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4794 - 4800.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freedman, M. S.
Right arrow Articles by Pachner, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freedman, M. S.
Right arrow Articles by Pachner, A. R.
Related Collections
Right arrow MRI
Right arrow All Immunology
Right arrow All Clinical Neurology
Right arrow Multiple sclerosis
Right arrowRelated Article